Product Information
BETAMETHASONE DP AUG 0.05% OIN is a generic product labeled by Actavis Pharma, Inc., priced at $1.4705 per GM under NDC 00472038245. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00472038245
Classification
Generic
Dosage Form
OINTMENT, AUGMENTED
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA074304FDA Approved
8/31/1995
TE Code
AB
On Market Since
9/1/1995
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP AUG 0.05% OIN has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 24.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4705 per GM |
|---|---|
| All-time high | $2.2017 (Apr 16, 2014) |
| All-time low | $1.1837 (Jul 17, 2024) |
| 52-week high | $1.4761 |
| 52-week low | $1.3345 |
| Median price | $1.6556 |
| Average price | $1.6675 |
| Largest weekly change | -22.5% (Jul 20, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP AUG 0.05% OIN?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP AUG 0.05% OIN, manufactured by Actavis Pharma, Inc., is $1.4705 per GM (NDC 00472038245), effective Sep 30, 2026.
How has the price of BETAMETHASONE DP AUG 0.05% OIN changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP AUG 0.05% OIN has declined 24.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP AUG 0.05% OIN?
Since Nov 28, 2013, the NADAC for BETAMETHASONE DP AUG 0.05% OIN has ranged from a low of $1.1837 (Jul 17, 2024) to a high of $2.2017 (Apr 16, 2014), with a median of $1.6556 per GM.
Are there cheaper alternatives to BETAMETHASONE DP AUG 0.05% OIN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP 0.05% OINT, is $0.3494 per GM — about 76% below BETAMETHASONE DP AUG 0.05% OIN.
Who manufactures BETAMETHASONE DP AUG 0.05% OIN?
BETAMETHASONE DP AUG 0.05% OIN (NDC 00472038245) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.